Login
Toggle navigation
Videos
Categories
Trending
Stephen Streater: CEO of Forbidden Technologies | Stephen Streater , CEO at Forbidden Technologies plc
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
The CEO of Forbidden Technologies plc is Stephen Streater.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Ecoener CEO Luis de Valdivia Debunks Myths About a Renewable Energy Bubble | Luis de Valdivia, CEO , Ecoener SA.
00:10:00
Ken MacKenzie Board of Directors, Chair OF BHP
00:10:00
Navigating Global Markets: Strategies from Fiona Lacey of Meridian Asset Management | Fiona Lacey – Senior Portfolio Strategist, Meridian Asset Management
00:00:00
Dr. Gregory Bayer, CEO, Brain Resource
00:10:00
Horace Mann CEO Marita Zuraitis and Springfield Public Schools present the 2018 Administrator of the Year award.
00:10:00
Find The Best Real Estate Solutions For You|Gary A. Pache,CEO,Camelot Group
00:00:00
Dr Luís Henrique Wolff Gowdak , Mayo Clinic
00:10:00
Tony Fabrizi of Blue Star Capital plc announces plans to raise up to £900,000 to facilitate a strategic shift in direction.
00:10:00
Tony Pidgley on the UK's Housing Market Challenges | Tony Pidgley, Chairman , Berkeley Group Holdings Plc.
00:10:00
Property Perspectives with Tan Sri Clement Hii | CLEMENT HII CHII KOK - FOUNDER & EXECUTIVE CHAIRMAN of HCK Capital Group
00:00:00
Development of a mobile system for managing type 1 diabetes - Eric Beard, Chairman and CEO of Cellnovo Group
00:10:00
Verdant Minerals: Navigating Towards Production and Expansion at One-to-One Mining Conference